Co-Diagnostics DSO Ratio 2011-2026 | CODX

Annual DSO Ratio Co-Diagnostics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
94.7	20.3	101	130	61.5	59.4	223	123	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
223	20.3	101

Quarterly DSO Ratio Co-Diagnostics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
83.8	97.3	244	-	51.9	-	-	-	35.4	876	467	-	181	308	85.4	-	41.5	41.5	55.3	-	50.8	46.1	361	-	289	195	1.94 K	-	126	126	63.1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.94 K	35.4	262

DSO Ratio of other stocks in the Diagnostics research industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	145	-	-6.23 %	$ 30.6 M	Germany
Agilent Technologies A	63.8	$ 117.17	1.83 %	$ 35.6 B	USA
Interpace Biosciences IDXG	66.9	$ 2.2	-4.35 %	$ 9.73 M	USA
Aspira Women's Health AWH	1.17 K	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	112	-	-13.05 %	$ 7.29 M	USA
Chembio Diagnostics CEMI	66.3	-	0.22 %	$ 16.8 M	USA
DermTech DMTK	80.6	-	-11.32 %	$ 2.94 M	USA
CareDx, Inc CDNA	51.5	$ 16.67	3.86 %	$ 888 M	USA
Oxford Immunotec Global PLC OXFD	90.8	-	-	$ 562 M	Britain
Myriad Genetics MYGN	52.3	$ 4.6	5.63 %	$ 426 M	USA
Akumin AKU	57.4	-	-17.87 %	$ 25.9 M	Canada
NeoGenomics NEO	77.7	$ 7.96	3.51 %	$ 1.02 B	USA
Enzo Biochem ENZ	50.3	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	30.8	-	-	$ 19.8 B	USA
Accelerate Diagnostics AXDX	291	-	-61.36 %	$ 2.46 M	USA
Castle Biosciences CSTL	49.2	$ 23.38	1.08 %	$ 649 M	USA
Global Cord Blood Corporation CO	112	-	-	$ 399 M	China
Fluidigm Corporation FLDM	67.2	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	11.7 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	122	-	0.12 %	$ 80.1 M	China
Charles River Laboratories International CRL	65	$ 177.66	1.14 %	$ 8.81 B	USA
Senseonics Holdings SENS	10.3	$ 6.69	0.15 %	$ 279 M	USA
PRA Health Sciences, Inc. PRAH	98.1	-	-	$ 10.7 B	USA
Medpace Holdings MEDP	50.4	$ 497.88	0.88 %	$ 14.4 B	USA
Danaher Corporation DHR	55.3	$ 194.98	2.83 %	$ 139 B	USA
Neuronetics STIM	48.7	$ 1.37	1.11 %	$ 90.4 M	USA
Heska Corporation HSKA	40.8	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	101	-	-20.0 %	$ 1.06 M	USA
Illumina ILMN	61.3	$ 125.77	4.0 %	$ 20 B	USA
Thermo Fisher Scientific TMO	70	$ 511.92	3.14 %	$ 193 B	USA
Fulgent Genetics FLGT	77.4	$ 15.3	5.99 %	$ 463 M	USA
Trinity Biotech plc TRIB	87.2	$ 0.71	-0.74 %	$ 61.9 M	Irlanda
Guardant Health GH	46.1	$ 81.33	3.47 %	$ 10.2 B	USA
QIAGEN N.V. QGEN	30.8	-	-	$ 10.6 B	Niderland
Anixa Biosciences ANIX	275	$ 2.79	3.72 %	$ 90.5 K	USA
Twist Bioscience Corporation TWST	44.5	$ 50.08	4.52 %	$ 3 B	USA
Biomerica BMRA	57.7	$ 2.09	-1.88 %	$ 4.8 M	USA
Invitae Corporation NVTA	242	-	-	$ 21.2 M	USA
ICON Public Limited Company ICLR	68.5	$ 110.47	3.43 %	$ 9.11 B	Irlanda
Soleno Therapeutics SLNO	27	$ 52.66	0.05 %	$ 2.68 B	USA
Laboratory Corporation of America Holdings LH	52.9	$ 264.01	1.18 %	$ 22 B	USA
Natera NTRA	81.5	$ 201.61	4.44 %	$ 19.8 B	USA
Lantheus Holdings LNTH	80.5	$ 81.19	0.74 %	$ 5.48 B	USA
Motus GI Holdings MOTS	77.2	-	-34.28 %	$ 263 K	Israel
Waters Corporation WAT	306	$ 322.55	0.75 %	$ 19.2 B	USA
Quest Diagnostics Incorporated DGX	44.9	$ 191.19	-0.17 %	$ 21.2 B	USA